Merit Medical Systems (NASDAQ:MMSI) Updates FY 2026 Earnings Guidance

Merit Medical Systems (NASDAQ:MMSI) updated its FY 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 4.010-4.150 for the period, compared to the consensus estimate of 3.730. The company issued revenue guidance of -, compared to the consensus revenue estimate of $1.6 billion.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on MMSI shares. Barrington Research reiterated an “outperform” rating and issued a $106.00 target price on shares of Merit Medical Systems in a research note on Friday, November 14th. Weiss Ratings reiterated a “hold (c)” rating on shares of Merit Medical Systems in a research report on Monday, December 29th. Canaccord Genuity Group boosted their price objective on Merit Medical Systems from $93.00 to $99.00 and gave the stock a “buy” rating in a research note on Wednesday, December 17th. Robert W. Baird set a $108.00 target price on Merit Medical Systems in a report on Tuesday, December 16th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $108.00 price target on shares of Merit Medical Systems in a report on Friday, January 9th. Nine investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $105.67.

Merit Medical Systems Trading Up 1.0%

MMSI traded up $0.82 during mid-day trading on Tuesday, hitting $82.43. The stock had a trading volume of 1,038,414 shares, compared to its average volume of 724,878. The stock’s fifty day simple moving average is $84.17 and its 200-day simple moving average is $85.01. The firm has a market capitalization of $4.89 billion, a price-to-earnings ratio of 42.27, a price-to-earnings-growth ratio of 2.23 and a beta of 0.61. Merit Medical Systems has a 1-year low of $77.62 and a 1-year high of $107.27. The company has a debt-to-equity ratio of 0.48, a current ratio of 4.28 and a quick ratio of 2.86.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings data on Tuesday, February 24th. The medical instruments supplier reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $0.96 by $0.08. The business had revenue of $393.94 million during the quarter, compared to analysts’ expectations of $390.77 million. Merit Medical Systems had a net margin of 8.02% and a return on equity of 14.27%. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. As a group, research analysts forecast that Merit Medical Systems will post 3.37 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of MMSI. State Street Corp grew its stake in Merit Medical Systems by 1.5% in the 4th quarter. State Street Corp now owns 2,231,048 shares of the medical instruments supplier’s stock valued at $196,645,000 after buying an additional 32,459 shares during the last quarter. Fuller & Thaler Asset Management Inc. grew its position in shares of Merit Medical Systems by 12.7% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 2,077,796 shares of the medical instruments supplier’s stock valued at $183,137,000 after purchasing an additional 234,682 shares during the last quarter. Wellington Management Group LLP increased its stake in shares of Merit Medical Systems by 7.0% during the fourth quarter. Wellington Management Group LLP now owns 1,327,013 shares of the medical instruments supplier’s stock worth $116,963,000 after purchasing an additional 86,504 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Merit Medical Systems by 4.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,225,013 shares of the medical instruments supplier’s stock worth $107,974,000 after purchasing an additional 47,151 shares during the last quarter. Finally, Morgan Stanley boosted its stake in Merit Medical Systems by 17.6% in the 4th quarter. Morgan Stanley now owns 1,140,390 shares of the medical instruments supplier’s stock valued at $100,514,000 after purchasing an additional 170,517 shares during the period. 99.66% of the stock is owned by institutional investors and hedge funds.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.